vendredi 5 juillet 2019

Onco Actu du 5 juillet 2019


2.6 ETIOLOGIE - ENVIRONNEMENT



Sydney's city council reviews use of Bayer's Roundup weed killer amid cancer fears [Reuters]











4. DÉPISTAGE, DIAGNOSTIC ET PRONOSTIC



Sports playbook helps doctors predict cancer patient outcomes [Stanford Medicine]










Scientists discover autoimmune disease associated with testicular cancer [Mayo Clinic]











4.2 DÉP., DIAG. & PRONO. - GÉNOME



Simpler name for cancer genetic syndrome could save lives [University of Washington]











5. TRAITEMENTS



Navigating the AML Treatment Algorithm in Era of Targeted Rx [Clinical Oncology News]











5.1 TRAITEMENTS - PRÉ-CLINIQUE



Treatment target pinpointed for liver cancer in young adults [University of Washington]











5.12.4 IMMUNOTHÉRAPIES - ESSAIS



Strain of common cold virus could revolutionise treatment of bladder cancer [ecancer news]











Common cold virus could cure cancer, pioneering trial suggests [The Telegraph]











Bladder cancer 'attacked and killed by common cold virus' [BBC News]











5.12.8 IMMUNOTHÉRAPIES - ECONOMIE



New skin cancer immunotherapy added to NHS England’s Cancer Drugs Fund [Cancer Research UK]











5.3 TRAITEMENTS - FDA, EMA, NICE...



Clinical trial sponsors called to publish results on EU database [European Pharmaceutical Review]











Medicine shortages: EU network takes steps to improve reporting and communication [EMA]










5.3.4 TRAITEMENTS - AMM (FDA, EMA,...)



FDA approves multiple myeloma therapy Xpovio despite safety concerns [Pharmafile]











Informed Consent Application for Azacitidine Celgene Received a Positive Opinion from the EMA [ESMO]











5.4 TRAITEMENTS - ECONOMIE



One lung cancer drug receives NHS England approval, while another is rejected [Cancer Research UK]











Life-extending lung cancer treatment recommended for use on the NHS [NICE]










NICE recommends Pfizer's Vizimpro, rejects AstraZeneca's Tagrisso, in non-small cell lung cancer [Pharmafile]











6.4 MÉDICO-ÉCO



Price Transparency in Health Care Is Coming to the U.S. — But Will It Matter? [Harvard Business Review]











Will price transparency reduce prices? [Healthcare Economist]